Advertisement
Screener

Edwards Lifesciences Corporation (EW) EBITDA

Edwards Lifesciences Corporation (EW) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $555.90M*; Operating income $513.20M; Depreciation and amortization $42.70M*.
  • 2026-03-31: Basis Reported; EBITDA $518.5M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $193.8M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $346.30M*; Operating income $307.10M; Depreciation and amortization $39.20M*.

Complete source-backed ebitda history.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$555.90M*$513.20M$42.70M*$1.74B31.93%*$66.90M*$651.90M*$392.40M$278.90M$561.20M$278.40M
2026-03-31Reported$518.5M(m)(m)(m)31.45%$64.90M$43.80M$362.60M$263.30M$522.20M$78.30M
2025-12-31Reported$193.8M(m)(m)(m)12.35%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$346.30M*$307.10M$39.20M*$1.55B22.30%*$57.50M*$573.70M*$345.20M$280.70M$514.60M$56.10M
2025-06-30Reported$449.30M*$411.20M$38.10M*$1.53B29.32%*$49.30M*$290.20M*$344.40M$276.20M$502.00M$64.30M
2025-03-31Reported$431.4M(m)(m)(m)30.54%$56.00M$280.40M$301.60M$254.60M$465.70M$70.30M
2024-12-31Reported$355.2M(m)(m)(m)25.63%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$385.10M*$350.60M$34.50M*$1.35B28.43%*$51.90M*$351.80M*$262.90M$253.40M$421.40M$40.70M
2024-06-30Reported$406.10M*$366.50M$39.60M*$1.37B29.66%*$85.40M*$371.50M*$275.50M$271.80M$447.50M$20.00M
2024-03-31Reported$387.5M(m)(m)(m)29.14%$65.30M-$53.50M$286.90M$256.70M$428.40M$46.30M
2023-12-31Reported$383.5M(m)(m)(m)30.28%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$402.80M*$365.90M$36.90M*$1.24B32.40%*$55.30M*$411.50M*$250.60M$242.80M$381.90M$52.70M
2023-06-30Reported$299.60M*$263.50M$36.10M*$1.28B23.43%*$47.90M*$33.60M*$256.90M$243.70M$410.40M$20.90M
2023-03-31Reported$423.6M(m)(m)(m)29.02%$61.50M$314.10M$329.50M$261.20M$436.30M$58.10M
2022-12-31Reported$233.1M(m)(m)(m)54.22%(m)(m)(m)(m)(m)(m)
2022-09-30Reported$437.80M*$402.40M$35.40M*$1.32B33.19%*$59.90M*$309.90M*$253.80M$233.60M$377.30M$63.80M
2022-06-30Reported$493.60M*$459.50M$34.10M*$1.37B35.93%*$43.10M*$332.20M*$269.40M$250.80M$409.00M$58.30M
2022-03-31Reported$473.5M(m)(m)(m)35.30%$72.70M$293.30M$299.30M$228.60M$370.30M$62.50M
2021-12-31Reported$407.4M(m)(m)(m)30.64%(m)(m)(m)(m)(m)(m)
2021-09-30Reported$423.90M*$390.30M$33.60M*$1.31B32.35%*$60.70M*$531.90M*$311.70M$238.00M$364.40M$50.80M
2021-06-30Reported$577.90M*$542.10M$35.80M*$1.38B42.00%*$69.30M*$526.10M*$334.30M$225.30M$374.50M$56.00M
2021-03-31Reported$415.9M(m)(m)(m)34.19%$106.00M$300.50M$293.40M$207.00M$330.80M$51.10M
2020-12-31Reported$384M(m)(m)(m)32.22%(m)(m)(m)(m)(m)(m)
2020-09-30Reported$383.40M*$357.80M$25.60M*$1.14B33.61%*$103.30M*$216.10M*$281.00M$195.50M$307.20M$39.10M
2020-06-30Reported-$145.20M*-$169.70M$24.50M*$925.00M-15.70%*$108.30M*$231.30M*$238.20M$182.10M$274.90M-$46.30M
2020-03-31Reported$382.6M(m)(m)(m)33.90%$82.20M$207.10M$265.10M$187.40M$307.80M$53.90M
2019-12-31Reported$334.7M(m)(m)(m)28.51%(m)(m)(m)(m)(m)(m)
2019-09-30Reported$317.40M*$294.30M$23.10M*$1.09B29.01%*$76.10M*$437.30M*$292.40M$195.50M$306.20M$27.00M
2019-06-30Reported$289.20M*$267.50M$21.70M*$1.09B26.61%*$64.60M*$341.20M*$304.00M$191.90M$308.50M$29.00M
2019-03-31Reported$294.8M(m)(m)(m)29.69%$42.20M$1.50M$231.80M$171.40M$280.30M$28.30M
2018-12-31Reported$14.6M(m)(m)(m)1.49%(m)(m)(m)(m)(m)(m)
2018-09-30Reported$268.10M*$248.90M$19.20M*$906.60M29.57%*$85.10M*$342.30M*$224.90M$161.80M$269.50M$22.80M
2018-06-30Reported$271.30M*$252.10M$19.20M*$943.70M28.75%*$52.80M*$140.20M*$246.20M$154.10M$274.90M-$31.70M
2018-03-31Reported$271.6M(m)(m)(m)30.35%$43.20M$151.30M$233.60M$143.20M$256.00M$56.90M
2017-12-31Reported$357.3M(m)(m)(m)40.21%(m)(m)(m)(m)(m)(m)
2017-09-30Reported$234.70M*$214.00M$20.70M*$821.50M28.57%*$42.30M*$310.80M*$213.30M$142.90M$244.60M$41.70M
2017-06-30Reported$259.90M*$241.00M$18.90M*$841.80M30.87%*$58.00M*$197.70M*$211.10M$134.40M$243.80M$19.50M
2017-03-31Reported$319.4M(m)(m)(m)36.15%$15.90M$128.30M$215.60M$128.70M$229.60M$63.40M
2016-03-31Reported(m)(m)$15.90M(m)(m)$27.70M(m)$180.30M$101.80M$212.70M$40.30M
2015-03-31Reported(m)(m)$16.00M(m)(m)$20.80M(m)$136.00M$86.40M$202.50M$39.10M
2014-03-31Reported(m)(m)$16.20M(m)(m)$14.30M(m)$145.90M$85.80M$197.20M$17.00M
2013-03-31Reported(m)(m)$14.10M(m)(m)$36.80M(m)$121.00M$79.80M$182.40M$46.70M
2012-03-31Reported(m)(m)$13.80M(m)(m)$18.00M(m)$127.30M$68.60M$177.20M$20.50M
2011-03-31Reported(m)(m)$14.50M(m)(m)$13.90M$14.90M$116.80M$59.00M$150.30M$20.70M
2010-03-31Reported(m)(m)$14.00M(m)(m)$8.00M$13.00M$98.60M$45.20M$134.00M$17.80M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$1.42B(m)(m)(m)23.42%$260.20M$1.60B$1.33B$1.08B$2.09B$216.90M
2024-12-31Reported$1.53B(m)(m)(m)28.20%$252.40M$542.30M$1.12B$1.05B$1.79B$152.10M
2023-12-31Reported$1.45B(m)(m)(m)29.02%$253.00M$895.80M$978.40M$962.90M$1.58B$152.40M
2022-12-31Reported$1.64B(m)(m)(m)36.69%$244.60M$1.22B$723.70M$843.60M$1.36B$195.50M
2021-12-31Reported$1.83B(m)(m)(m)34.88%$325.80M$1.73B$1.25B$903.10M$1.49B$198.90M
2020-12-31Reported$1B(m)(m)(m)22.91%$407.00M$1.05B$1.08B$760.70M$1.23B$93.30M
2019-12-31Reported$1.24B(m)(m)(m)28.43%$254.40M$1.18B$1.11B$752.70M$1.24B$119.60M
2018-12-31Reported$825.6M(m)(m)(m)22.18%$238.70M$926.70M$939.40M$622.20M$1.09B$39.20M
2017-12-31Reported$1.17B(m)(m)(m)34.10%$168.10M$1.00B$875.30M$552.60M$990.80M$451.30M
2016-12-31Reported$822.4M(m)(m)(m)27.75%$176.10M$704.40M$797.40M$442.20M$904.70M$168.40M
2015-12-31Reported(m)(m)$65.80M(m)(m)$102.70M$549.70M$617.20M$382.90M$850.70M$127.50M
2014-12-31Reported(m)(m)$68.60M(m)(m)$82.90M(m)$625.60M$346.50M$858.00M$332.90M
2013-12-31Reported(m)(m)$62.90M(m)(m)$109.00M(m)$516.60M$323.00M$733.40M$122.10M
2012-12-31Reported(m)(m)$53.70M(m)(m)$109.00M(m)$491.00M$291.30M$697.40M$96.70M
2011-12-31Reported(m)(m)$58.00M(m)(m)$76.60M(m)$489.80M$246.30M$642.40M$46.90M
2010-12-31Reported(m)(m)$56.50M(m)(m)$61.80M$251.40M$408.30M$204.40M$550.00M$50.20M
2009-12-31Reported(m)(m)$58.70M(m)(m)$64.00M$165.30M$399.10M$175.50M$508.80M$75.30M
2008-12-31Reported(m)(m)$55.60M(m)(m)$50.60M$153.20M$419.60M$139.20M$480.60M$35.50M

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00